Human Health TDC
AMAP Thematic Data Centres compile data from relevant monitoring and research activities and make them available under strict conditions that protect the rights of data originators. AMAP TDCs are located at established centres with appropriate expertise and facilities for conducting the types of international data handling required. For more information, please visit the main AMAP website.
Below are projects that have specified Human Health TDC as one of the data repositories for the AMAP Project Directory. To see the full list of AMAP Thematic Data Centres, see the AMAP TDC list.
It is also possible to browse and query the full list of projects.
To edit or add records to any of the catalogs, log in or create an account.
Persistent organic pollution is a global problem. This fact is especially apparent in the Arctic where pesticides currently used in distant environments accumulate, in some cases to higher levels than those observed in the source region. This pollution threatens the well-being of the aboriginal inhabitants of these regions. Most of the traditionally harvested animals in the Arctic are long-lived and from the higher trophic levels of the food chain, thereby providing an opportunity for considerable bioaccumulation and biomagnification of persistent contaminants. This has prompted a growing concern by the Alaska Inupiat that pollutants in the environment might be contributing to their unique morbidity and mortality rates, especially of their children. Our studies are currently focused on two specific organic pollutants found in the Arctic environment; 1}hexachlorobenzene (HCB), a byproduct during manufacture of several different chlorinated compounds and consistently detected in the Arctic and, 2} dichlorodiphenyl dichloroethylene (p,p’-DDE), a chlorinated environmental breakdown product measured in the Arctic population at significantly higher concentrations than the parent pesticide, DDT. We hypothesize that mammalian embryonic cell exposure to these chemicals, individually or as mixtures at environmentally relevant concentrations and ratios, will alter the cell cycle and/or cause death by apoptosis, rather than by necrosis. We also predict synergistic cytotoxicity of the chemical mixture because of an accumulation of deleterious effects at different cellular target sites by each chemical. We further hypothesize that while some chemicals target non-genetic cellular components (such as a cell membrane or cytosolic component), other chemical effects will occur primarily at the genetic level, directly or indirectly. Our experiments have been designed as a set of sensitive cellular and molecular assays to compare levels and types of cytotoxic and genotoxic activity of the above chemicals (individual and mixture), at environmentally relevant concentrations, upon embryonic cells in culture. Our experimental evidence thus far is that these chemicals, separately or as a mixture at concentrations and molar ratios relevant to that measured in the Arctic environment, do have cytotoxic and/or genotoxic effects that could result in profound consequences to exposed tissues of a developing embryo or fetus. We have further experimental evidence that exposure to both chemicals at environmentally relevant concentrations is more toxic to the cell than the sum of effects by exposure to the individual chemicals. Experimental results indicate this is due to different cellular target sites for each chemical (Appendix A: Preliminary Results).
The objectives of the centre are: - to provide access to data from recent human health monitoring and research activities conducted as part of the AMAP national implementation plans. - to provide a means to ensure treatment of data in a consistent manner, uniform statistical analysis etc., including application of objective quality assurance procedures. - to begin the process of establishing a long-term archive of relevant Arctic monitoring data for use in future assessments of temporal trends etc. - to meet the ministerial request from the Alta Conference to include human health data in the AMAP thematic data centres.